- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06911047
Dementia Prevention Internet-Based Intervention: Randomized Controlled Trial and Knowledge Translation
In this proposal, the investigators plan to study the effectiveness of a web-based intervention on dementia prevention knowledge, intentions, and behaviour change related to dementia risk. Participants will be randomized to one of two groups - intervention and control. Participants randomized to the intervention group will receive the dementia prevention e-learning. Participants in the control group will be assigned an alternate-topic e-learning lesson. All participants will be given access to all e-learning at the conclusion of the study.
The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.
The investigators will also engage in participatory co-design with community partners using focus groups to determine pragmatic ways to effectively disseminate e-learning programs to support knowledge about dementia and preventative measures within equity-deserving groups.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
With our aging population, the prevalence of dementia is increasing dramatically. Developing a better understanding of how dementia can be prevented and sharing information about how Canadians can reduce their risk of developing dementia or delay its onset is critical to keeping Canadians healthy and improving quality of life. Web-based interventions in dementia have been shown to be effective for a range of outcomes, but very few have been widely implemented or rigorously studied; additionally, national, and provincial guidelines have all highlighted the importance of online resources to improve dementia prevention education. This has been further brought into focus by the coronavirus pandemic. While there have been studies of web-based health information on intentions and behaviour change, the vast majority of those studies have looked at text-based health information, rather than internet-based interventions that have incorporated best practices in instructional design for e-learning. The investigators developed a high-quality, award-winning web- and email-based dementia prevention education platform for care partners, which includes asynchronous, multimedia e-learning lessons and email-based 'micro-learning' content to reinforce the learning. The investigators recently conducted a Randomized Controlled Trial (RCT) of an internet-based, multi-media, instructionally designed dementia prevention intervention (DementiaRisk) in Canadian adults without a diagnosis of dementia. Results, which are currently being prepared for publication, showed that the DementiaRisk resource improved knowledge, intentions to engage in healthy behaviours, and health behaviours related to dementia risk reduction, and was positively rated and well accepted by participants. This resource is now publicly accessible at DementiaRisk.ca.
However, we know that people who live in poverty are more likely to develop dementia compared to people of higher socioeconomic status. Lower level of education in childhood is a known risk factor for dementia, but there are many other social determinants of health (e.g., income, employment, housing, and others) that may impact knowledge and behaviours related to dementia risk or protective factors. A range of positive effects have been shown for web-based interventions for various target audiences (e.g., health care providers and family/friend care partners), on a wide range of outcomes (e.g., knowledge, attitudes, burden, stress, and others). Interventions delivered through the web also allow for greater accessibility to a multitude of users, facilitating scale and spread. We therefore wish to study the impact of the DementiaRisk resource in a new equity-deserving population.
Objective:
In this proposal, the investigators plan to study the effectiveness of our web-based intervention on dementia prevention knowledge, intentions, and behaviour change.
Methods:
Design, Setting, and Participants:
This study is a sequential explanatory mixed methods design randomized controlled trial. Following eligibility screening, informed consent, and baseline socio-demographic measures, participants will be randomized either to the intervention group or the control group. Those adults (age ≥ 16) who have no prior diagnosis of dementia, have internet and email access, and are fluent in English will be eligible to participate in the RCT. Participants will be randomized and directed to their assigned learning path after submitting online informed consent and baseline measures using the Division of e-Learning Innovation's research platform. Participants will be randomized using a block randomization. To the best of our ability, efforts will be made to blind participants to their allocation group and study hypotheses.
Focus groups will be conducted with 6-10 representative participants (not involved in the RCT) including: intervention agents/organization staff and leaders, people who identify as low income, people who identify as family/friend care partners of people living with dementia, and/or people living with dementia.
Intervention:
Participants randomized to the intervention group will receive the dementia prevention e-learning. Participants in the control group will be assigned an alternate-topic e-learning lesson. All participants will be given access to all e-learning at the conclusion of the study.
Focus groups will use an interview guide informed by the CFIR Framework.
Outcomes:
The purpose of this phase is to explore if and how our dementia prevention e-learning influences participants' knowledge, intentions and health behaviours related to dementia risk.
The specific aims are:
- To evaluate whether exposure to the e-learning intervention changes knowledge of dementia risk factors, intention to engage in risk reduction activities, and health behaviours related to dementia prevention.
- To explore qualitative aspects such as participants' engagement and satisfaction with the intervention, as well as barriers and facilitators to use, through surveys and synchronous online focus groups.
Focus groups will focus on better understanding barriers and facilitators for uptake, use, and dissemination of e-learning within a lower-income setting.
Implications and Relevance:
The results of this study will contribute to the planning of a larger randomized controlled trial (RCT) in the future; as well as the evaluation of innovative, cost-effective, and efficient dementia prevention resources that can complement traditional approaches. The intervention could be easily scaled and spread to complement other dementia education methods. Focus groups will help to inform further implementation and scale and spread to disadvantaged populations.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S4L8
- McMaster University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Inclusion Criteria:
- No prior diagnosis of dementia
- Live in Canada
- 16 years of age and over
- Good command of the English language
- Access to email and internet
- Comfortable using email and internet, and
- Ability to grant online informed consent
Exclusion Criteria:
- Prior diagnosis of dementia
- Lives outside of Canada
- Not 16 years of age or over
- Does not speak English,
- Does not have access to email or internet
- Is not comfortable using email of internet
- Does not grant informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Education Intervention
Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components:
|
Participants in the intervention group will be provided e-learning about dementia prevention and promoting brain health, consisting of following components: 1.
One multimedia e-learning lesson on promoting brain health and preventing dementia; 2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to dementia risk factors
|
|
Active Comparator: Education Control
Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components:
|
Participants in the control group will be provided e-learning about mild cognitive impairment, consisting of following components: 1.
One multimedia e-learning lesson on mild cognitive impairment; 2. A series of 12 'micro-learning' emails (3 emails/week) with small segments of content to reinforce the material from the lesson.
3. Curated resources related to mild cognitive impairment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1. Knowledge change (custom 15-item knowledge questionnaire related to key dementia prevention modifiable risk factors
Time Frame: 0 weeks, 4 weeks, 12 weeks
|
A custom 15-item knowledge questionnaire (multiple true-false response) to measure change related to key dementia prevention modifiable risk factors.
Items are pulled from other validated surveys (i.e., Dementia Knowledge Assessment Scale) and key dementia prevention modifiable risk factors.
|
0 weeks, 4 weeks, 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intentions change (custom 10-item intentions questionnaire related to key dementia prevention modifiable risk factors)
Time Frame: 0 weeks, 4 weeks, 12 weeks
|
Intentions related to dementia prevention.
A custom 10-item intentions questionnaire (7 point Likert scale) to measure intentions to change related to key dementia prevention modifiable risk factors.
Items were created based on key modifiable risk factors related to dementia as identified by the 2020 Lancet Commission Report.
|
0 weeks, 4 weeks, 12 weeks
|
|
Behaviour change related to dementia prevention (custom 42-item health behaviours questionnaire)
Time Frame: 0 weeks, 4 weeks, 12 weeks
|
Behaviour change related to dementia prevention.
A custom 42-item health behaviours questionnaire (Likert response options) to measure health behaviours related to key dementia prevention modifiable risk factors.
Items are pulled from other validated surveys (Health and Behaviour Survey, Godin Leisure Time Exercise Questionnaire, World Health Organization for smoking status, etc.) and key dementia prevention modifiable risk factors.
|
0 weeks, 4 weeks, 12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention adherence (time spent)
Time Frame: 4 weeks
|
Lesson completion data, email open rates, and resource downloads will be collected and saved to quantify the time(s) spent on intervention activities.
|
4 weeks
|
|
Participant satisfaction
Time Frame: 4 weeks
|
A custom satisfaction questionnaire data adapted from the Information Assessment Method For All (IAM4all) will be collected and saved to assess satisfaction with the intervention.
|
4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Neurocognitive Disorders
- Tauopathies
- Neurodegenerative Diseases
- Alzheimer Disease
- Dementia
- Health Services
- Health Care Facilities Workforce and Services
- Child Health Services
- Community Health Services
- Preventive Health Services
- Early Intervention, Educational
Other Study ID Numbers
- Levinson_DCI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia Prevention
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Baycrest; Alzheimer Society of... and other collaboratorsRecruitingCognitive Change | Mild Cognitive Impairment | Lifestyle Intervention | Dementia Prevention | Subjective Cognitive Impairment | Dementia EducationCanada
-
McMaster UniversityPublic Health Agency of Canada (PHAC)Completed
-
University of CoimbraFundação para a Ciência e a TecnologiaRecruitingPrevention | Cognitive Health | Dementia Risk FactorsPortugal
-
Gia Dinh People HospitalNot yet recruitingMild Cognitive Impairment | Dementia Prevention
-
BaycrestCompletedDementia | Mild Cognitive Impairment | Dementia Prevention | Subjective Cognitive Impairment | Pre-dementiaCanada
-
Alzheimer's Disease Cooperative Study (ADCS)CompletedDementia | Alzheimer's Disease | Dementia PreventionUnited States
-
University of ZurichWaid City Hospital, ZurichCompletedMild Cognitive Impairment | Mild Dementia | Fall PreventionSwitzerland
-
Fundacion CITA-alzheimerBiogipuzkoa Health Research InstituteCompletedCognitive Decline | Prevention | Dementia Risk Factors | Multidomain InterventionSpain
-
Aristotle University Of ThessalonikiUnknown
Clinical Trials on Education Intervention
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Roswell Park Cancer InstituteCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedAdvanced Malignant NeoplasmUnited States
-
Mayo ClinicTerminated
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedMalignant NeoplasmUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphatic System NeoplasmUnited States
-
Fred Hutchinson Cancer CenterPrevent Cancer FoundationCompleted
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy